![AnnKatrin Petersen-Jappelli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
AnnKatrin Petersen-Jappelli
No más puestos en curso
Historial de carrera de AnnKatrin Petersen-Jappelli
Antiguos cargos conocidos de AnnKatrin Petersen-Jappelli.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MIGENIX, Inc.
![]() MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Director Técnico/Científico/I+D | 01/05/2006 | - |
Corporate Officer/Principal | 01/05/2006 | 24/03/2010 | |
QUALIGEN THERAPEUTICS, INC. | Director Técnico/Científico/I+D | - | - |
Agouron Pharmaceuticals LLC
![]() Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Director Técnico/Científico/I+D | 01/01/1996 | 07/04/2011 |
Corporate Officer/Principal | 07/04/2011 | - |
Formación de AnnKatrin Petersen-Jappelli.
University of Lausanne | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 3 |
Canadá | 2 |
Suiza | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
MIGENIX, Inc.
![]() MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |
Agouron Pharmaceuticals LLC
![]() Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Health Technology |
Ritter Pharmaceuticals, Inc.
![]() Ritter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA. | Health Technology |